Literature DB >> 22865233

α5 β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes.

Holger Gohlke1, Birte Schmitz, Annika Sommerfeld, Roland Reinehr, Dieter Häussinger.   

Abstract

UNLABELLED: Ursodeoxycholic acid, which in vivo is converted to its taurine conjugate tauroursodeoxycholic acid (TUDC), is a mainstay for the treatment of cholestatic liver disease. Earlier work showed that TUDC exerts its choleretic properties in the perfused rat liver in an α5 β1 integrin-mediated way. However, the molecular basis of TUDC-sensing in the liver is unknown. We herein show that TUDC (20 μmol/L) induces in perfused rat liver and human HepG2 cells the rapid appearance of the active conformation of the β1 subunit of α5 β1 integrins, followed by an activating phosphorylation of extracellular signal-regulated kinases. TUDC-induced kinase activation was no longer observed after β1 integrin knockdown in isolated rat hepatocytes or in the presence of an integrin-antagonistic hexapeptide in perfused rat liver. TUDC-induced β1 integrin activation occurred predominantly inside the hepatocyte and required TUDC uptake by way of the Na(+) /taurocholate cotransporting peptide. Molecular dynamics simulations of a 3D model of α5 β1 integrin with TUDC bound revealed significant conformational changes within the head region that have been linked to integrin activation before.
CONCLUSIONS: TUDC can directly activate intrahepatocytic β1 integrins, which trigger signal transduction pathways toward choleresis. (HEPATOLOGY 2013).
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865233     DOI: 10.1002/hep.25992

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

Review 1.  Novel therapeutic targets in primary biliary cirrhosis.

Authors:  Jessica K Dyson; Gideon M Hirschfield; David H Adams; Ulrich Beuers; Derek A Mann; Keith D Lindor; David E J Jones
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

2.  The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.

Authors:  Yuhuan Wang; Xiaoxi Liu; Sonja S Pijut; Jianing Li; Jamie Horn; Emily M Bradford; Markos Leggas; Terrence A Barrett; Gregory A Graf
Journal:  J Lipid Res       Date:  2015-01-29       Impact factor: 5.922

3.  Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death.

Authors:  Debby Laukens; Lindsey Devisscher; Lien Van den Bossche; Pieter Hindryckx; Roosmarijn E Vandenbroucke; Yves-Paul Vandewynckel; Claude Cuvelier; Brigitta M Brinkman; Claude Libert; Peter Vandenabeele; Martine De Vos
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

4.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

5.  The human platelet antigen-1b (Pro33) variant of αIIbβ3 allosterically shifts the dynamic conformational equilibrium of this integrin toward the active state.

Authors:  Giulia Pagani; Joana P V Pereira; Volker R Stoldt; Andreas Beck; Rüdiger E Scharf; Holger Gohlke
Journal:  J Biol Chem       Date:  2018-02-09       Impact factor: 5.157

Review 6.  Roles of Ileal ASBT and OSTα-OSTβ in Regulating Bile Acid Signaling.

Authors:  Paul A Dawson
Journal:  Dig Dis       Date:  2017-03-01       Impact factor: 2.404

Review 7.  Effects of bile acids on neurological function and disease.

Authors:  Matthew McMillin; Sharon DeMorrow
Journal:  FASEB J       Date:  2016-07-28       Impact factor: 5.191

8.  Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate.

Authors:  Annika Sommerfeld; Patrick G K Mayer; Miriam Cantore; Dieter Häussinger
Journal:  J Biol Chem       Date:  2015-08-25       Impact factor: 5.157

Review 9.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

Review 10.  Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.

Authors:  Bryan L Copple; Tiangang Li
Journal:  Pharmacol Res       Date:  2015-12-17       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.